🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Singapore / NCT06622681
Recruiting Observational

Integrative Adolescence Research Programme (IARP)

NCT06622681 · tracked via the Priya Life Science Singapore tracker
Phase
Observational
Started
2024-05-21
Last updated
2025-12-30

Condition(s) studied

Executive DysfunctionPhysical StressMental Health Wellness 1

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

This study aims to understand child health during adolescence. We will examine the role of lifestyle (e.g. physical activity), growth trajectories and other environmental factors that can influence the development of phenotypes in adolescence which confer risk for later physical and mental disorders. With this study, we will develop a deeper understanding of adolescent health and well-being and their main determinants in the local Singaporean context, identify levers for early interventions to mitigate challenges to adolescent health and well-being and enhance protective factors for adolescents to do well in life, contribute to society and maximize their potential.

Eligibility

Sex
ALL
Min age
13 Years
Max age
15 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Aged 13 to 15 years of age 2. Currently studying in MOE registered school 3. Part of the DREAMS study Exclusion Criteria: 1. Not in MOE registered school 2. Not part of the DREAMS study

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
A*STAR Institute for Human Development and Potential (IHDP) Singapore Singapore Recruiting
Singapore Institute of Clinical Sciences Singapore Singapore Enrolling By Invitation

More Institute for Human Development and Potential (IHDP), Singapore trials in Singapore

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06622681 on ClinicalTrials.gov ↗ ← All trials in Singapore